Researchers are excited to announce they have started clinical trials to develop a protective vaccine against HIV. This is a huge milestone for the EAVI2020 project and is the first clinical trial to assess how different protein combinations influence the development of protective antibodies. The first dose was administered on March 28 at NIHR Imperial CRF, Hammersmith Hospital, London, with another 50 participants to take part over a 12-month period. Read More
Reading Time: < 1 minute They are the third most commonly used form of contraception in the UK, behind the Pill and the hormonal implant, official data…
Reading Time: < 1 minute An increasing number of people catching the sexually transmitted infection are finding it does not respond to antibiotics. Read More
Reading Time: < 1 minute Sexually transmitted infections (STIs) and reproductive tract infections (RTIs) are major global health issues, impacting quality of life, causing infertility, cancers, and…
Subscribe to our Blog
Let's stay in touch. Subscribe to our blog and get our best content in your inbox.
